Dendritic Cells Activated by Lipopolysaccharide after Dexamethasone Treatment Induce Donor-Specific Allograft Hyporesponsiveness
Authors:
- Johan Van Der VlagJVJohan Van Der Vlag
- Gosse J AdemaGAGosse J Adema
- Luuk B HilbrandsLHLuuk B Hilbrands
- 27 May 2006
- journal article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 81 (10) , 1451-1459
Abstract
Immature dendritic cells (imDC) can prolong allograft survival in murine transplantation models. Recent data indicate that semi-mature or alternatively activated DC (aaDC) may be even more tolerogenic. We compared the phenotype and regulatory capacity of: a) imDC, cultured in the presence of dexamethasone (DEX), b) mature DC (matDC), activated with LPS, and c) aaDC, activated with LPS after pretreatment with DEX. As compared to imDC, aaDCs displayed a slight upregulation of CD40 while expression levels of MHC-II and CD86 remained low. The production of proinflammatory cytokines, in particular IL-12, by aaDC was much lower than by matDC while both produced similar amounts of the regulatory cytokine IL-10 leading to an increased IL-10/IL-12 ratio for aaDC. After infusion of donor type aaDCs, responder cells isolated from the recipient mice showed donor-specific hyporesponsiveness to restimulation by matDC. Infusion of matDC was immunogenic, while imDC induced partial hyporesponsiveness. Importantly, pretreatment with donor type aaDC (but not imDC) resulted in prolonged survival of a completely MHC-mismatched heart allograft. Alternatively activated DC are more efficacious than the classical imDC in the regulation of the alloimmune response, which may be related to a distinct cytokine profile characterized by an increased IL-10/IL12 ratio.Keywords
This publication has 39 references indexed in Scilit:
- Enhancement of Folate Receptor α Expression in Tumor Cells Through the Glucocorticoid Receptor: A Promising Means to Improved Tumor Detection and TargetingCancer Research, 2005
- A new carboxamide compound exerts immuno-suppressive activity by inhibiting dendritic cell maturationEuropean Journal of Immunology, 2005
- Prolongation of skin graft survival by modulation of the alloimmune response with alternatively activated dendritic cells1Transplantation, 2003
- Direct and indirect cross-tolerance of alloreactive T cells by dendritic cells retained in the immature stage1Transplantation, 2002
- Differential involvement of IFN- in Toll-like receptor-stimulated dendritic cell activationInternational Immunology, 2002
- Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?Trends in Immunology, 2002
- Ubiquitin (UbC) Expression in Muscle Cells Is Increased by Glucocorticoids through a Mechanism Involving Sp1 and MEK1Journal of Biological Chemistry, 2002
- Repetitive Injections of Dendritic Cells Matured with Tumor Necrosis Factor α Induce Antigen-specific Protection of Mice from AutoimmunityJournal of Experimental Medicine, 2001
- Prolongation of Cardiac Allograft Survival Using Dendritic Cells Treated with NF-κB Decoy OligodeoxyribonucleotidesMolecular Therapy, 2000
- Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation.Journal of Experimental Medicine, 1992